UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 383

Sortiert nach

Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives

Cancers, 2021-02, Vol.13 (4), p.634

2021

Link zum Volltext

Verfügbarkeit prüfen

Histone Deacetylase 6‑Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity

Journal of medicinal chemistry, 2018-09, Vol.61 (17), p.8054-8060

2018

Link zum Volltext

Verfügbarkeit prüfen

Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)

Angewandte Chemie (International ed.), 2020-12, Vol.59 (50), p.22494-22499

International ed. in English, 2020

Link zum Volltext

Verfügbarkeit prüfen

Fluorescent Ligands Enable Target Engagement Studies for the Intracellular Allosteric Binding Site of the Chemokine Receptor CXCR2

Journal of medicinal chemistry, 2023-07, Vol.66 (14), p.9916-9933

2023

Link zum Volltext

Verfügbarkeit prüfen

HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder

Human molecular genetics, 2016-09, Vol.25 (18), p.3887-3907

2016

Link zum Volltext

Verfügbarkeit prüfen

A General Approach for Preparation of Polymer-Supported Chiral Organocatalysts via Acrylic Copolymerization

Journal of organic chemistry, 2010-03, Vol.75 (5), p.1620-1629

2010

Link zum Volltext

Verfügbarkeit prüfen

Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors

Molecules (Basel, Switzerland), 2023-01, Vol.28 (3), p.1061

2023

Link zum Volltext

Verfügbarkeit prüfen

EDTA aggregates induce SYPRO orange-based fluorescence in thermal shift assay

PloS one, 2017-05, Vol.12 (5), p.e0177024-e0177024

2017

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Acrylic Polymer Beads for Solid-Supported Proline-Derived Organocatalysts

Organic letters, 2009-07, Vol.11 (14), p.2968-2971

2009

Link zum Volltext

Verfügbarkeit prüfen

Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy

Pharmaceuticals (Basel, Switzerland), 2023-02, Vol.16 (3), p.356

2023

Link zum Volltext

Verfügbarkeit prüfen

Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors

International journal of molecular sciences, 2020-11, Vol.21 (21), p.8300

2020

Link zum Volltext

Verfügbarkeit prüfen

Development of the first geldanamycin-based HSP90 degraders

Frontiers in chemistry, 2023-06, Vol.11, p.1219883-1219883

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of novel HDAC inhibitors on urothelial carcinoma cells

Clinical epigenetics, 2018-07, Vol.10 (1), p.100-100, Article 100

2018

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi)

International journal of molecular sciences, 2020-07, Vol.21 (13), p.4747

2020

Link zum Volltext

Verfügbarkeit prüfen

New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science: Joint Virtual Special Issue by Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, and ACS Pharmacology & Translational Science

ACS medicinal chemistry letters, 2021-10, Vol.12 (10), p.1508-1509

2021

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs

Pharmaceuticals (Basel, Switzerland), 2022-03, Vol.15 (3), p.333

2022

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Chemical Innovative Approaches in Cancer Molecular Medicine and Translational Clinical Research

Frontiers in chemistry, 2020-09, Vol.8, p.820-820

2020

Link zum Volltext

Verfügbarkeit prüfen

Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [ 18 F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain

Pharmaceuticals (Basel, Switzerland), 2022-03, Vol.15 (3), p.324

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeted Protein Degradation of Histone Deacetylases by Hydrophobically Tagged Inhibitors

ACS medicinal chemistry letters, 2023-12, Vol.14 (12), p.1863-1868

2023

Link zum Volltext

Verfügbarkeit prüfen

Histone Deacetylase (HDAC) Inhibitors with a Novel Connecting Unit Linker Region Reveal a Selectivity Profile for HDAC4 and HDAC5 with Improved Activity against Chemoresistant Cancer Cells

Journal of medicinal chemistry, 2013-01, Vol.56 (2), p.427-436

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficient synthesis and 5-LOX/COX-inhibitory activity of some 3-hydroxybenzo[b]thiophene-2-carboxylic acid derivatives

Bioorganic & medicinal chemistry letters, 2012-08, Vol.22 (15), p.5031-5034

2012

Link zum Volltext

Verfügbarkeit prüfen

Discovery of the First-in-Class Dual Histone Deacetylase–Proteasome Inhibitor

Journal of medicinal chemistry, 2018-11, Vol.61 (22), p.10299-10309

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1β release

Biochemical pharmacology, 2023-09, Vol.215, p.115693-115693, Article 115693

2023

Link zum Volltext

Verfügbarkeit prüfen

Development of the first non-hydroxamate selective HDAC6 degraders

Chemical communications (Cambridge, England), 2022-10, Vol.58 (79), p.1187-119

2022

Link zum Volltext

Verfügbarkeit prüfen

Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity

Journal of medicinal chemistry, 2022-12, Vol.65 (24), p.16860-16878

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 383

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(344)
Mit Volltextzugriff
(362)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(255)
Life Sciences & Biomedicine
(181)
Humans
(135)
Female
(72)
Physical Sciences
(70)
Biological And Medical Sciences
(57)
Male
(57)
Adult
(55)
Chemistry
(52)
Medical Sciences
(51)
Middle Aged
(49)
Pharmacology & Pharmacy
(44)
Chemistry, Medicinal
(41)
Aged
(36)
Animals
(36)
Physics
(29)
Histone Deacetylase Inhibitors - Pharmacology
(28)
Oncology
(25)
Histone Deacetylase
(23)
Exact Sciences And Technology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives

Histone Deacetylase 6‑Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity

Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)

Fluorescent Ligands Enable Target Engagement Studies for the Intracellular Allosteric Binding Site of the Chemokine Receptor CXCR2

HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder

A General Approach for Preparation of Polymer-Supported Chiral Organocatalysts via Acrylic Copolymerization

Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors

EDTA aggregates induce SYPRO orange-based fluorescence in thermal shift assay

Synthesis of Acrylic Polymer Beads for Solid-Supported Proline-Derived Organocatalysts

Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy

Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors

Development of the first geldanamycin-based HSP90 degraders

Effects of novel HDAC inhibitors on urothelial carcinoma cells

In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi)

New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science: Joint Virtual Special Issue by Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, and ACS Pharmacology & Translational Science

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs

Editorial: Chemical Innovative Approaches in Cancer Molecular Medicine and Translational Clinical Research

Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [ 18 F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain

Targeted Protein Degradation of Histone Deacetylases by Hydrophobically Tagged Inhibitors

Histone Deacetylase (HDAC) Inhibitors with a Novel Connecting Unit Linker Region Reveal a Selectivity Profile for HDAC4 and HDAC5 with Improved Activity against Chemoresistant Cancer Cells

Efficient synthesis and 5-LOX/COX-inhibitory activity of some 3-hydroxybenzo[b]thiophene-2-carboxylic acid derivatives

Discovery of the First-in-Class Dual Histone Deacetylase–Proteasome Inhibitor

Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1β release

Development of the first non-hydroxamate selective HDAC6 degraders

Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity

Suchergebnisse filtern